Seminars and Symposia
IDAC Seminar to commemorate the retirement of Professor Fukuda, 28 February 2013
|Secretariat, Alumni Association, IDAC|
|Date||Thursday, 28 February 2013, 18:00〜|
|Room||Smart Aging Research Building International Conference Room|
|Title||Cancer diagnosis with positron emission tomography (PET): Developmental stage to clinical practice.|
|Affiliation||Department of Nuclear Medicine and Radiology, Institute of Development,
Aging and Cancer (IDAC), Tohoku University
|Person-in-charge||Hideo Shimomura Dept.Nuclear Medicine and Radiology
(Contact: Chie Sugawara ex8559)
|Abstract||In 1981，we, Tohoku University group, started experimental study for cancer diagnosis with PET. We demonstrated that F-18 fluorodeoxyglucose (FDG) accumulated much in cancer tissues and that F-18 fluorodeoxymannose (FDM), which is an analog of FDG, was almost the same potential for cancer imaging as that of FDG. We firstly reported lung cancer imaging with PET using C-11 methionine Further, we developed F-18 fluorodeoxygalactose for the quantitative measurement of galactose metabolism in the liver and visualization of hepatocellular carcinoma (HCC).
In 2002, the government decided the coverage of FDG PET examination by health insurance system. This decision was owed by the great efforts by board members of Japanese Society of Nuclear Medicine, including Fukuda. This triggered the wide use of PET and now 300 PET centers are active in Japan.
Development of new radiopharmaceurticals for PET cancer imaging is still being continued from view points of new knowledge of cancer biology.